Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Loblaw Companies Ltd T.L.PR.B


Primary Symbol: T.L Alternate Symbol(s):  LBLCF | LBLPF

Loblaw Companies Limited is a Canada-based food and pharmacy retailer. The Company provides grocery, pharmacy and healthcare services, health and beauty products, apparel, general merchandise, financial services, and wireless mobile products and services. The Company’s segments include Retail and Financial Services. The Retail segment consists primarily of corporates and franchise-owned retail... see more

TSX:L - Post Discussion

Loblaw Companies Ltd > TD Raise Target
View:
Post by retiredcf on Jul 29, 2022 1:26pm

TD Raise Target

Loblaw Companies Ltd.

(L-T) C$117.09

Tonnage is Not What the Simple Math Suggests Event

  • Raising our annual EPS estimates by 3-4% to reflect the Q2/22 beat, slightly higher Drug sales/margins, and slightly lower Retail SG&A growth. We now expect adjusted EPS growth of 18% in 2022E (guidance is for mid-high teens), and 9%/10% in 2023E/2024E.

  • Rolling out our target valuation another quarter increases our target price to $130.00 (from $125.00).

    Impact: SLIGHTLY POSITIVE

    Q2/22 EPS jumped 25% y/y on the back of strong Drug gross margins (larger mix of pharmacy services, beauty/cosmetics, and OTC revenues) and less-than- expected opex growth. Despite the beat, and an increase in 2022E EPS guidance, the shares fell almost 4% yesterday. The shares were very strong heading into the quarter, but investor concerns around weaker-than-expected implied Food tonnage (and possible market-share erosion) seemed to fuel the underperformance. We view these concerns as unwarranted — the much lower-than-expected "Street math" tonnage (-8.7%) seems to be mostly related to the effects of trading down and channel mix shifts, rather than market-share erosion, as the inflation number (up ~9.6%) is based on a fixed basket, which does not capture trade-down and, as such, is an "inflated" figure. [We attempt to shed some light on this using two simplistic examples in Exhibit 2.] Loblaw gained market share in the Conventional channel this quarter, but lost some in the Discount channel to Walmart and Costco, though Loblaw already took steps to address this slippage early in Q3/22.

    We see inflation peaking in Q2/22, though remaining >7% in H2/22 (many vendors have reportedly asked for additional price increases), before slipping more rapidly over H1/23.

    TD Investment Conclusion

    Loblaw is well-positioned among the grocers, given its disproportionate exposure to pharmacy, the discount channel, and private label. Coupled with enhanced merchandising strategies and alternative profit streams (e.g., Media, Connected Health), we forecast EPS growth of 15% over the rest of 2022 (vs 9%/13%, normalized, for Metro/Empire). In the short term, we still see good relative performance for Loblaw, particularly after yesterday’s pullback and earnings raise. That said, as inflation moderates, we could see more investor funds move into the processors in search of greater risk/reward.

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities